# OnCo record nct06011109 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06011109/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06011109", "NCT06011109" ;
  schema:name "Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab"@en ;
  schema:description "A phase 1/2 trial of APG-157 in glioma & glioblastoma, run by Aveta Biomics, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06011109/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06011109> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2023-12-13" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:companies <https://onco.cc/companies/aveta-biomics/> .